ClinicalTrials.Veeva

Menu

The Relationship Between White Matter Hyperintensity With Cognition and Emotion

Zhejiang University logo

Zhejiang University

Status

Unknown

Conditions

Leukoaraiosis
Aged

Study type

Observational

Funder types

Other

Identifiers

NCT02761148
Z14H180003

Details and patient eligibility

About

White matter hyperintensity (WMH) has been found to be related with cognitive and emotional dysfunction. A presumed mechanism is that WMH disrupts the structural connectivity within a large-scale brain network, thereby impairing the brain's ability to integrate the neural processes efficiently. It is not yet clear, what the pattern of brain network disruption relates to WMH and how the brain network disruption induced by WMH has an effect on cognition and emotion performance. Using multi-model magnetic resonance imaging (MRI) techniques, we aimed to explore the mechanisms of cognitive decline and depression related with brain network dysfunction in patients with WMH, and to provide objective imaging marker for early diagnosis and prevention of WMH associated cognitive decline and depression.

Enrollment

200 estimated patients

Sex

All

Ages

35 to 85 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  1. white matter hyperintensity visible on T2 fluid-attenuated inversion recovery images;
  2. age between 35 to 80 years;
  3. without stroke lesion (except lacunar infarction) on current diffusion weighted images;
  4. without a history of multiple sclerosis, Alzheimer's disease, Parkinson's disease and head trauma.

Exclusion criteria

  1. white matter lesions of nonvascular origin (immunological-demyelinating, metabolic, toxic, infectious, other);
  2. intracranial hemorrhage;
  3. with severe head motion on magnetic resonance images

Trial design

200 participants in 2 patient groups

Control
White matter hyperintensity

Trial contacts and locations

1

Loading...

Central trial contact

Minming Zhang, Ph.D

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems